Caitong International Asset Management Co., LTD Cabaletta Bio, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 8,983 shares of CABA stock, worth $20,750. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,983Holding current value
$20,750% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
83Shares Held
72.8MCall Options Held
1.1MPut Options Held
14.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$22.4 Million7.24% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$20.4 Million0.03% of portfolio
-
Jennison Associates LLC8.5MShares$19.6 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.36MShares$19.3 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$11.6 Million1.86% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $67M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...